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Innate immune receptors, notably Toll-like receptors
(TLRs) and RIG-I-like receptors (RLRs), sense viral
infection and activate transcription factors, including
interferon regulatory factor-3 (IRF3), to induce type I
interferon (IFN). We demonstrate that the lipid phos-
phatidylinositol-5-phosphate (PtdIns5P) is increased
upon viral infection and facilitates type I IFN produc-
tion by binding to IRF3 and its upstream kinase TBK1
and promoting TBK1-mediated IRF3 phosphoryla-
tion and activation. Additionally, we determine that
PtdIns5P is produced through the kinase PIKfyve,
which phosphorylates PtdIns to generate PtdIns5P.
Accordingly, PIKfyve knockdown or pharamoclogi-
cal inhibition decreases PtdIns5P levels and type I
IFN production after TLR or RLR stimulation, and
results in increased viral replication. A synthetic
PtdIns5P, C8-PtdIns5P, promotes IRF3 phosphory-
lation and cytokine production in dendritic cells and
acts as an adjuvant to boost immune responses in
immunized mice. Thus, PtdIns5P produced during
viral infection is a second messenger that targets
the TBK1-IRF3 axis to elicit antiviral immunity.
INTRODUCTION
Detection of pathogen components and subsequent induction of
innate immune responses, such as the production of inflamma-
tory cytokines and type I interferon (IFN), is mediated by
pattern-recognition receptors (PRRs), including Toll-like recep-
tors (TLRs), RIG-I-like receptors (RLRs), C-type lectin receptors,
NOD-like receptor,rs and intracellular sensors for DNA (AIM2,
DAI, DDX41, LRRFIP1, MRE11, and cGAS) (Kawai and Akira,
2011; Kondo et al., 2013; Sancho and Reis e Sousa, 2012;
Strowig et al., 2012; Sun et al., 2013). These receptors trigger
intracellular signaling pathways that lead to the coordinated148 Cell Host & Microbe 14, 148–158, August 14, 2013 ª2013 Elseviactivation of several transcription factors, including members
of the interferon regulatory factor (IRF) and NF-kB families.
Among these, IRF3 controls expression of IFNb and other cyto-
kine genes during viral and bacterial infection. In the steady
state, IRF3 is localized in the cytoplasm and translocates to
the nucleus by forming a dimer after viral infection or stimulation
with bacterial lipopolysaccharide (LPS). IRF3 activation is initi-
ated by phosphorylation of serine and threonine clusters in its
C terminus by the serine/threonine kinases TANK-binding kinase
1 (TBK1) and IkB kinase i (IKKi) (Fitzgerald et al., 2003).
The TBK1-IRF3 axis is activated by multiple stimuli and plays
critical roles in the induction of type I IFN (Honda et al., 2006).
TLR3 and TLR4, which recognize viral double-stranded (ds)
RNA and LPS, respectively, activate TBK1 and IRF3 through
an adaptor, TRIF. RLRs are composed of RIG-I and MDA5,
which sense RNA species from various RNA viruses. RLRs re-
cruit an adaptor protein, IPS-1 (also known as MAVS, Cardif,
or VISA), and eventually activate TBK1-IRF3 signaling. The
TBK1-IRF3 axis is also involved downstream of STING, is
required for induction of the cytosolic DNA-mediated type I
IFN-inducing pathway, and was shown to be essential for DNA
vaccine-induced innate and adaptive immune responses (Ishii
et al., 2008). However, the detailed mechanisms of how the
TBK1-IRF3 axis is regulated remain unclear.
Phosphatidylinositol (PtdIns) lipids regulate a variety of bio-
logical responses, including signal transduction, organelle traf-
ficking, cytoskeletal regulation, and innate immune responses.
PtdIns4P, produced by the kinase PI4KIIIa, is required for
hepatic virus C entry and replication (Berger and Randall,
2009). PtdIns3,4,5P3 has been proposed to regulate innate
immune signaling (Koyasu, 2003). Deficiency of the p85a subunit
of PI3K, which generates PtdIns3,4,5P3, enhances NF-kB
activation through AKT and GSK3b and increases cytokine
production. Deficiency of PTEN, a PtdIns3,4,5P3 phosphatase,
leads to constitutively enhanced PI3K signaling activity.
PtdIns3P from PI3K binds to the p40phox and p47phox oxidase
complex and enhances reactive oxygen production for bacterial
defense (Koyasu, 2003). Contributions of PI3K in IRF3- and
IRF7-mediated innate immune signaling have been discussed
(Guiducci et al., 2008; Hrincius et al., 2011). It was shown thater Inc.
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Figure 1. PtdIns5P Enhances IRF3 Phosphorylation by TBK1 In Vitro
(A) Fractionated cellular components were subjected to in vitro kinase assay by incubation with recombinant IRF3 (rIRF3) and TBK1 (rTBK1) (left) or IKKi (rIKKi)
(right), and IRF3 phosphorylation was detected by an anti-pS394IRF3 antibody.
(B) Lipid interactions with IRF3 (left) or TBK1 (right) were detected by protein lipid overlay assay.
(C) PE/PC-based liposomes with the indicated synthetic C16-PtdIns were subjected to in vitro kinase assay by incubation with rIRF3 and rTBK1. Figure 1 is
related to Figure S1.
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PtdIns5P Promotes Antiviral Innate ImmunityShigella flexneri inject PtdIns4,5P2-4-phosphatase into host cells
to increase cellular PtdIns5P production, which supports their
survival (Pendaries et al., 2006).
Here, we screened cellular components and identified
PtdIns5P as a facilitator of TBK1-mediated IRF3 phosphoryla-
tion. PtdIns5P is produced from PIKfyve, which phosphorylates
the phosphatidylinositol ring at the 50 position. Intracellular levels
of PtdIns5P were increased in mammalian cells after dsRNA
stimulation and viral infection. PtdIns5P directly bound to IRF3
and caused IRF3 activation by facilitating IRF3 phosphorylation
via TBK1. Notably, synthetic water-soluble C8-PtdIns5P acted
as an agonist of the TBK1–IRF3 axis and enhanced adaptive im-
mune responses in vivo. Taken together, these findings suggest
that PtdIns5P is a second messenger in antiviral innate immune
signaling.
RESULTS
Identification of PtdIns5P
To identify cellular components that regulate the TBK1-IRF3
axis, we set up an in vitro screening system. We prepared re-
combinant TBK1 and IRF3, and these were mixed with various
reagents in the presence of ATP. After the in vitro kinase reaction,
we detected IRF3 activation by immunoblotting using an anti-
body against S396-phosphorylated IRF3. We incubated TBK1
and IRF3 together with DMXAA (a vascular disrupting agent
that activates STING), dsDNA (poly[dA:dT]), high KCl concentra-
tion, H2O2, or recombinant STING, but none of these enhanced
IRF3 phosphorylation (see Figure S1A online and data not
shown). We then tested whether cellular components partici-
pated in IRF3 phosphorylation. To this end, we separated
HEK293T cells into water-soluble and -insoluble fractions using
chloroform/methanol. The water-insoluble fraction (chloroform
layer), which contains lipids or cholesterol, was dried and resus-
pended in reaction buffer. Thewater-insoluble fraction increased
IRF3 phosphorylation by TBK1 and IKKi (Figure 1A). Moreover,
the water-insoluble fraction isolated from HEK293T cells trans-
fected with IPS-1 strongly induced IRF3 phosphorylation,
compared with controls (Figure S1B), indicating that lipids
enriched in activated cells are responsible for TBK1-mediated
IRF3 activation.Cell HosTo further identify the lipids involved in IRF3 activation, we
screened lipids bound to TBK1 or IRF3 using a protein lipid over-
lay (PLO) assay. TBK1 bound to PtdIns5P, and IRF3 bound to
several anionic lipids including PtdIns5P (Figure 1B). No binding
of these proteins to cationic or other lipids was detectable (data
not shown). This suggests that phosphatidylinositols can pro-
mote IRF3 phosphorylation in vitro. To examine the involvement
of these phosphatidylinositols in IRF3 activation, various syn-
thetic phosphatidylinositols were mixed with phosphatidylcho-
line (PC) and phosphatidylethanolamine (PE) to form liposomes
and subjected to the in vitro kinase assay. Among the phospha-
tidylinositols, PtdIns5P-containing liposomes facilitated IRF3
phosphorylation (Figure 1C). Overexpression of TBK1 caused
autoactivation of TBK1 (Clark et al., 2009). Therefore further
increase of TBK1 phosphorylation at S172 might not be
observed (Figure 1C). TBK1 phosphorylation was not increased
in in vitro kinase assay using endogenous TBK1 precipitated
from RAW264.7 cells (Figure S1C), suggesting that TBK1 phos-
phorylation at S172 was not affected by PtdIns5P.
Identification of PIKfyve
We next sought to identify the kinases or phosphatases respon-
sible for production of PtdIns5P during viral infection (Figure 2A).
To this end, HEK293 cells were transfected with an expression
plasmid for the candidate genes together with an IFN-stimulated
response element (ISRE) reporter plasmid, and luciferase
expression was measured by reporter assay. Luciferase expres-
sion increased with overexpression of PIKfyve, a kinase that
synthesizes PtdIns5P or PtdIns3,5P2 by phosphorylation of
position 5 in the inositol ring (Figure S2A). Previous studies using
overexpression of PIKfyve or cells deficient for PIKfyve demon-
strated that PIKfyve mediates PtdIns5P production (Ikonomov
et al., 2011; Sbrissa et al., 2002). PIKfyve is a 250 kDa protein
containing a fyve domain and a kinase domain. We found that
protein and mRNA level of PIKfyve expression were increased
with poly(I:C) (synthetic analog of dsRNA recognized by TLR3
or RLRs), poly(dA:dT) and RNA virus, and Newcastle disease
virus (NDV) stimulation, but not by LPS stimulation (Figure S2B).
Overexpression of PIKfyve in HEK293 cells increased ISRE and
IFNb promoter activity but did not influence NF-kB promoter
activity (Figure 2B). In contrast, a kinase-negative mutant oft & Microbe 14, 148–158, August 14, 2013 ª2013 Elsevier Inc. 149
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B Figure 2. PIKfyve Activates the IFNb
Promoter
(A) Schematic model of PtdIn5P generation and
related candidate genes.
(B) HEK293 cells were transfected with control,
PIKfyve, or kinase-negative (kn) PIKfyve expres-
sion plasmids together with reporter plasmids
driven by IFNb (top), ISRE (middle), or NF-kB
(bottom). Luciferase expression was measured.
Data are represented as mean ± SD.
(C) Expression of PIKfyve and kn PIKfyve was
detected in the same transfection condition with
(B). Figure 2 is related to Figure S2.
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PtdIns5P Promotes Antiviral Innate ImmunityPIKfyve (kn PIKfyve) failed to activate these promoters upon
overexpression. Expression levels were comparable between
wild-type and kinase-negative PIKfyve, suggesting that mutation
of PIKfyve at K1831M did not affect the protein stability (Fig-
ure 2C). These results suggested that PtdIns5P production by
PIKfyve regulates IFNb production.
Roles of PIKfyve in the TBK1-IRF3 Axis Signaling
Pathway
To address whether PIKfyve regulates antiviral innate immune
responses, we utilized YM-201636, a PIKfyve inhibitor (Jefferies
et al., 2008). Expression of IFNb mRNA induced by LPS,
poly(I:C), and DNA was abrogated by YM-201636 treatment in
mouse embryonic fibroblast (MEF) cells (Figure 3A). IFNb and
IP-10 production was suppressed by YM-201636 in a dose-
dependent manner (Figure S3A), but LPS- and R837 (TLR7
ligand)-induced TNF-a production in GM-CSF-induced bone
marrow-derived dendritic cells (GM-DCs) was not affected (Fig-
ure S3B). To clarify the signaling pathway, we quantified NF-kB
activity by ELAM-luciferase and IRF activity by ISRE-luciferase
in HEK293 cells (Figure 3B). ISRE activation by LPS, poly(I:C),
and poly(dA:dT) stimulation was suppressed, but NF-kB activa-
tion was not. In addition, IRF3 phosphorylation after stimulation
with LPS, poly(I:C) or interferon stimulatory DNA (ISD) (synthetic
dsDNA) was suppressed by YM-201636 treatment in GM-DCs,
but phosphorylation of RelA, a member of the NF-kB family,
was not affected (Figure 3C and Figure S3C). Furthermore,
YM-201636 treatment suppressed IRF3 dimer formation in
response to poly(I:C) but did not influence phosphorylation of150 Cell Host & Microbe 14, 148–158, August 14, 2013 ª2013 Elsevier Inc.JNK or p38 (Figure 3D). NDV and HSV-1
(DNA virus)-induced IFNb expression in
MEF cells was also suppressed by YM-
201636 (Figure 3E).
Knockdown of PIKfyve in MEF cells
suppressed production of IFNb after
LPS, poly(I:C), or ISD stimulation (Fig-
ure 4A, Figures S4A and S4B). However,
TNF-a expression after LPS or R837
stimulation was comparable (Figure 4B).
IRF3 phosphorylation and dimer forma-
tion were suppressed by PIKfyve knock-
down, but RelA phosphorylation was not
affected (Figures 4C and 4D and Fig-
ure S4C). JNK and p38 phosphorylationwere also not affected (Figure S4D). In addition, NDV- and
HSV-1-dependent IFNb production and IRF3 phosphorylation
were also abrogated by PIKfyve knockdown in MEF cells
(Figure 4E) and GM-DCs (Figures S4E and S4F). Virus titers
of NDV were increased by PIKfyve knockdown in MEF cells
(Figure 4F). Reduction of IRF3 activity by PIKfyve knockdown
was also supported by a luciferase assay in HEK293 cells (Fig-
ure 4G, Figures S4G–S4I). Collectively, these results suggest
that PIKfyve is required for the TBK1-IRF3 axis activation in
innate immune signaling.
Increased PtdIns5P Production in Innate
Immune Signaling
PtdIns5P production is increased by several stimuli (Wilcox and
Hinchliffe, 2008), and PIKfyve appears to be the main source for
production of PtdIns5P, suggested by analyses of gene-defi-
cient mice (Ikonomov et al., 2011). Wemeasured PtdIns5P levels
in MEF cells by the PtdIns5P mass assay. Radioactive-labeled
lipids were separated by TLC (Figure 5A, left), and the intensities
measured by densitometry were plotted as a bar graph (Fig-
ure 5A, right). Production of PtdIns5P increased upon stimulation
with poly(I:C), LPS, or infection with NDV (Figures 5A and B).
H2O2 was used as a positive control (Jones et al., 2006). To
confirm that poly(I:C)-induced PtdIns5P production is depen-
dent on PIKfyve, PtdIns5P production was measured after YM-
201636 treatment or PIKfyve knockdown (Figures 5C and 5D).
Time course experiments indicated that production of PtdIns5P
increased to peak levels at 15 min after poly(I:C) stimulation and
decreased gradually thereafter. However, cells pretreated with
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Figure 3. PIKfyve Kinase Inhibitor Suppresses IFNb Production
(A) MEF cells pretreated with 0.5 mM YM-201636 for 30 min were stimulated with LPS, poly(I:C), poly(dA:dT), or ISD transfection, and expression of IFNbmRNA
was measured by qPCR.
(B) HEK293 cells pretreated with YM-201636 were stimulated with LPS, poly(I:C), or poly(dA:dT). Activation of ISRE and NF-kB promoter was measured by
luciferase assay. HEK293-expressing TLR4/MD2/CD14 cells were used for LPS stimulation.
(C) GM-DCs were stimulated with LPS or transfected with poly(I:C) and ISD, and immunoblotting was performed with the indicated antibodies.
(D) IRF3 dimer formation was detected by native-PAGE analysis (top), and p38 and JNK phosphorylation were detected by SDS-PAGE followed by immuno-
blotting (bottom).
(E) MEF cells were infected with NDV (top) or HSV-1 (bottom) after treatment with YM-201636. IFNb production wasmeasured by ELISA. Data are represented as
mean ± SD. Figure 3 is related to Figure S3.
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PtdIns5P Promotes Antiviral Innate ImmunityYM-201636 failed to show increased PtdIns5P production (Fig-
ure 5C). Similarly, knockdown of PIKfyve abrogated poly(I:C)-
induced PtdIns5P production (Figure 5D). Although PtdIns5P
mainly accumulated in the nucleus in the steady state (Jones
et al., 2006), PIKfyve localized in the cytosol and endosome-
like structures in MEF cells (Figure 5E) (Rutherford et al., 2006).
PIKfyve in endosome-like structures only partially colocalized
with STING or other endosomemarkers (Figure 5E), and localiza-
tion of PIKfyve did not dramatically change after poly(I:C), LPS,
or DNA stimulation (data not shown). Although the localization
of PIKfyve is not clear, PtdIns5P production after poly(I:C) in
the cytosol was three times higher than basal levels (Figure 5F).
However, PtdIns5P production in the nucleus was almost
comparable. These results suggest that increase of cytosolic
PtdIns5P produced from PIKfyve is important for regulation of
the TBK1-IRF3 axis. Although mechanisms of how PIKfyve
activity is controlled are not clear, one possibility is that the
binding of PIKfyve to IPS-1 and TRIF induces PIKfyve activation
(Figure 5G).
PtdIns5P Binds the LRH Pocket of IRF3
Autophosphorylation of TBK1 at S172 was reported to be linked
to its activation (Clark et al., 2009; Kishore et al., 2002), but
phosphorylation at S172 was not inhibited by PIKfyve inhibitor
or knockdown (Figure 3C, Figures S3C and S4C). In addition,
TBK1 phosphorylation after LPS or R837 stimulation was clearly
observed, but not by poly(I:C) or ISD stimulation, which is consis-
tent with a recent study (Figure 3C and Figure S3C) (Clark et al.,
2011). These results suggested that increased phosphorylationCell Hosand activation of TBK1 are not always related to IRF3 phosphor-
ylation. Furthermore, the in vitro kinase assay demonstrated
that addition of PtdIns5P did not induce detectable enhance-
ment of TBK1 phosphorylation (Figure 1C, Figures S1B and
S1C). These findings suggest that TBK1 is not a critical target
for PtdIns5P in terms of IRF3 activation.
Next, we examined whether IRF3 association with PtdIns5P
was important for its regulation. Based on the human IRF3 struc-
ture, several clusters of anionic amino acids at the surface
of IRF3 were proposed to be a regulatory domain and may
bind electrostatically to PtdIns5P (Qin et al., 2003; Takahasi
et al., 2003). We investigated IRF3-PtdIns5P interactions by
PLO assay using recombinant hIRF3 containing anionic amino
acids replaced by Ala. The K360A/R361A mutation of hIRF3
had a lower affinity for PtdIns5P than wild-type IRF3 (Figure 6A).
In addition, the K360A/R361A mutant did not induce PtdIns5P-
dependent IRF3 phosphorylation at S396 in vitro (Figure 6B).
The cellular functional role of K360/R361 was tested by the
rescue of wild-type or mutant murine IRF3 in Irf3/ MEF cells.
K352/R353 (homologous amino acid to K360/R361 in hIRF3) in
mIRF3 is critical for phosphorylation, dimer formation (Figure 6C),
and cytokine gene expression (Figure 6D and Figure S5A). These
results collectively suggested that the PtdIns5P interaction with
K360/R361 in hIRF3 is important for TBK1-IRF3 axis activation.
In addition to IRF3 phosphorylation, we also examined whether
PtdIns5P from PIKfyve could regulate the interaction between
TBK1 and IRF3. HEK293T cells were cotransfected with IRF3
and TBK1 or TBK1 kinase negative (kn), and cells were treated
with YM-201636 (Figure 6E). TBK1-IRF3 interactions weret & Microbe 14, 148–158, August 14, 2013 ª2013 Elsevier Inc. 151
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Figure 4. PIKfyve Knockdown Suppresses IFNb Production by Reducing IRF3 Activation
(A–F) mPIKfyve knockdown by siRNA electroporation in MEF cells. (A) MEF cells were stimulated with LPS or transfected with poly(I:C), poly(dA:dT), or ISD, and
expression of IFNbmRNAwasmeasured by qPCR. (B) Expression of TNF-amRNAwas quantified by qPCR after stimulation with LPS or R837. (C)MEF cells were
stimulated with LPS or transfected with poly(I:C) or ISD, and immunoblotting was performedwith the indicated antibodies. (D) IRF3 dimer formation was detected
by native PAGE analysis. (E) MEF cells were infected with NDV or HSV-1, and expression of IFNbmRNAwasmeasured by qPCR. (F) MEF cells were infected with
NDV at moi 0.1, and virus titer was measured after 24 hr by qPCR.
(G) hPIKfyve in HEK293 cells was knocked down by siRNA electroporation. ISRE or ELAM promoter plasmid was cotransfected with TRIF, IPS-1, or STING
expression plasmid, and promoter activity was measured by luciferase assay. Data are represented as mean ± SD. Figure 4 is related to Figure S4.
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PtdIns5P Promotes Antiviral Innate Immunitysuppressed by YM-201636 treatment, suggesting that PtdIns5P
production from PIKfyve regulated substrate-kinase binding and
phosphorylation. The kinase mutation in TBK1 also abrogated
TBK1-IRF3 interactions, indicating that the interactions are
mediated by its catalytic activity.
Interestingly, K360/R361 in hIRF3 is located in a cleft, termed
the loop-helix region (LHR) pocket (Takahasi et al., 2003). To gain
further insight into the mechanism of interaction, we simulated
docking around the LHR pocket with the AutoDock4 and
AutoDock Vina programs (Morris et al., 2009; Trott and Olson,
2010). Inositol1,5P2, the inositol head of PtdIns5P, was used
for the calculation, and docked conformations with a free phos-
phate group at position P1 were selected based on their energy
(Figure 6F, Figures S5B and S5C). Both simulations provided
very similar results. The docking result supported a model in
which the inositol head of PtdIns5P is electrostatically stabilized
by R361 in the LHR pocket and forms hydrogen bonds with the
surrounding amino acids. Membrane surface interaction might
be supported by dimer formation in order to enhance associa-
tion (Figure S5D). In addition, based on the above results,
K360 might be important for electrostatic interactions with the
lipid membrane.
Cytokine Production and Adjuvant Effects
of Synthetic C8-PtdIns5P
PIKfyve produces PtdIns5P from PtdIns and PtdIns3,5P2 from
PtdIns3P by phosphorylation of the 50 position in the inositol152 Cell Host & Microbe 14, 148–158, August 14, 2013 ª2013 Elseviring (Ikonomov et al., 2011; Sbrissa et al., 2002). To obtain direct
evidence for PtdIns5P involvement in TBK1-IRF3 signaling,
we investigated whether exogenous administration of synthetic
PtdIns5P could induce cytokine production. Among the phos-
phatidylinositols phosphorylated at the 50 position in the ring,
treatment of GM-DCs with C8-PtdIns5P (a water-soluble lipid
with a eight acyl chain) induced production of IP-10 and
RANTES, but not IL-1b (Figure 7A and Figure S6A). In contrast,
C8-PtdIns5P did not induce cytokine production from MEF or
M-CSF-inducedmacrophages (Figure S6B and data not shown).
Stimulation with water-insoluble C16 acyl chain phosphatidyli-
nositol did not induce cytokine production (Figure S6C). To
investigate whether production of these cytokines wasmediated
through the IRF3 signaling axis, we examined cytokine pro-
duction in GM-DCs from IPS-1- or IRF3/IRF7-deficient mice.
Irf3 and Irf7 gene expression partially compensate for each other
and share PtdIns5P binding amino acids (Honda et al., 2006).
Although wild-type and IPS-1 (MAVS)-deficient GM-DCs
showed increased IP-10, RANTES, and IFNb production
following C8-PtdIns5P stimulation, IRF3/IRF7-deficient GM-
DCs showed diminished production of these cytokines (Fig-
ure 7B). C8-PtdIns5P induced phosphorylation and dimer
formation of IRF3 in GMDCs, but not Rel A phosphorylation
(Figures S6D and S6E). Furthermore, C8-PtdIns5P treatment
increased IFNa/b mRNA expression in MEF cells, but not in
TBK1/IKKi-deficent MEF cells, suggesting C8-PtdIns5P-medi-
ated activation requires TBK1/IKKi (Figure S6F). These resultser Inc.
AD
F
G
B C
E
Figure 5. PtdIns5P Production Increases in MEF Cells after Stimulation
(A) The left panel shows the results of a representative PtdIns5P quantification experiment. PtdIns was isolated after stimulation using neomycin-coated beads,
and PtdIns5P was converted to PtdIns4,5P2 by PI5P4K in the presence of [gamma
32P] ATP. PtdIns4,5P2 was separated by TLC, and densitometry was
measured. The bar graph shows mean densitometry values normalized to the control level.
(B–D) Time course of PtdIns5P production after NDV stimulation (moi 5) (B), poly(I:C) stimulation during YM-201636 treatment (C), or PIKfyve knockdown (D).
(E) MEF cells were cotransfected with GFP-PIKfyve and STING-RFP, and were stained with anti-Tom20 or anti-Lamp1.
(F) MEF cells were separated to cytosol and nucleus fraction, and PtdIns5P production was measured after PtdIns isolation.
(G) HEK293T cells were cotransfected with PIKfyve and indicated expression plasmid. Flag-tagged proteins were precipitated with anti-Flag agarose beads, and
proteins were analyzed by immunoblotting using anti-PIKfyve or anti-Flag. Data are represented as mean ± SD.
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PtdIns5P Promotes Antiviral Innate Immunityindicated that PtdIns5P from PIKfyve targets TBK1/IKKi-IRF3/7
signal for cytokine production.
The cytokine production induced by C8-PtdIns5P in DCs
prompted us to test whether C8-PtdIns5P acts as an adjuvant.
C57BL/6J mice were immunized intramuscularly with ovalbumin
(OVA) plus PBS, C8-PtdIns5P, or C8-PtdIns4,5P2 or were immu-
nized intraperitoneally with OVA plus alum as a positive control,
and after immunization OVA-specific total IgG in sera were
measured. Mice immunized OVA and C8-PtdIns5P produced
higher titers of OVA-specific IgG than did mice immunized withCell HosOVA and PBS or C8-PtdIns4,5P2 (Figure 7C). Increased levels
of IgG1, but not other subclasses such as IgG2, IgG3, or IgA,
were observed after four immunizations with C8-PtdIns5P
(data not shown). The antigen-specific IgG production by
PtdIns5P was diminished in IRF3/7-deficient mice, whereas the
production by Alum was comparable between wild-type and
IRF3/7-deficient mice (Figure 7D) (Marichal et al., 2011). Next,
we investigated whether T cell activation was induced by
PtdIns5P. In this regard, OVA-specific OT-II-transgenic CD4+
T cells were cocultured with GM-DCs treated with C8-PtdIns5P,t & Microbe 14, 148–158, August 14, 2013 ª2013 Elsevier Inc. 153
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Figure 6. IRF3 Binding to PtdIns5P Is Critical for Signal Transduction
(A) Wild-type rIRF3 and mutant rIRF3 containing R211A/R213A, R285A/H288A/H290A, or K360A/R361A were purified and stained with Coomassie brilliant blue
(CBB) after SDS-PAGE. Nitro cellulosemembranes blottedwith the indicated amount of PtdIns5Pwere incubatedwith the indicated proteins and binding proteins
were detected by anti-IRF3.
(B) rIRF3 or mutant rIRF3 as subjected to in vitro kinase assay by incubation with PtdIns5P containing PC/PE liposomes.
(C and D) Wild-type MEF cells were infected with control retrovirus, and IRF3/ MEF cells were infected with retrovirus expressing wild-type or K352A/R353A
IRF3. (C) MEF cells were stimulated by poly(I:C) transfection, then immunoblotting was performed with the indicated antibodies, and IRF3 dimer formation was
detected by native PAGE analysis. (D) Expression of IFNb mRNA was measured by qPCR.
(E) HEK293T cells were transfected with IRF3 and TBK1 wild-type or TBK1 kinase negative (kn). Cells were treated with or without YM-201636, and binding
protein to TBK1 was analyzed.
(F) (Left) Results of docking simulation with inositol1,5P2 and IRF3 by Autodock vina are shown around LHR pocket. Blue indicates molecular surface of a side
chain of Arg 361. (Right) Schematic representation of inositol1,5P2 is shown by the same direction with the left. P1 site should be linked by acyl chain. Data are
from one experiment represented of three (A, B, C, and E). Data are represented as mean ± SD (D). Figure 6 is related to Figure S5.
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PtdIns5P Promotes Antiviral Innate ImmunityC8-PtdIns4,5P2, or poly(I:C) in the presence of OVA protein,
and IFNg production was measured (Figure 7E). C8-PtdIns5P
treatment induced IFNg production, whereas C8-PtdIns4,5P2
treatment did not. Therefore, these findings suggest that C8-
PtdIns5P has an adjuvant-like property and induces antibody
production through Th1 cell responses.
DISCUSSION
We showed that IFNb induction through innate receptors is regu-
lated by PtdIns5P, which targets the TBK1-IRF3 signaling axis.
By in vitro kinase assay, IRF3 phosphorylation was barely
detected, even in the presence of TBK1, whereas addition of
PtdIns5P markedly induced IRF3 phosphorylation (Figure 1).
These results suggest that phosphorylation sites on IRF3 are
masked by other regions of IRF3 unless PtdIns5P is bound.
Our docking simulation suggests that inositol1,5P2, the head of154 Cell Host & Microbe 14, 148–158, August 14, 2013 ª2013 ElseviPtdIns5P, fits into the LHR pocket of IRF3. In addition, the PLO
assay demonstrates that R360 and R361 are necessary for bind-
ing to PtdIns5P (Figure 6). Therefore, we speculate that PtdIns5P
binding may induce a conformational change in IRF3 to expose
phosphorylation sites to which TBK1 gains access (Figure S6G).
Although PtdIns5P also binds to TBK1 in vitro, it does not
affect TBK1 phosphorylation at S172. This suggests that
PtdIns5P facilitates complex formation between TBK1 and
IRF3, increasing the accessibility of TBK1 to IRF3, causing
IRF3 phosphorylation in a proximal manner, but without affecting
TBK1 activation. Alternatively, TBK1 S172 phosphorylation
may not always reflect TBK1 activation during viral infection.
Ubiquitination of TBK1 linked to K63 was reported to be an
important modification for its activity (Li et al., 2011), suggesting
that PtdIns5P binding to TBK1 may influence ubiquitination.
Moreover, PtdIns5P binding to TBK1may induce the recruitment
of proteins such as TANK, NAP1, NEMO, and TRAF3, whicher Inc.
AC
B
D E
Figure 7. C8-PtdIns5P Induces Cytokine Production and Functions as an Adjuvant
(A) IP-10 and RANTES production from GM-DCs stimulated with the indicated C8-lipids were measured by ELISA.
(B) GM-DCs fromwild-type, IRF3//IRF7/ or IPS-1 (MAVS)/mice were stimulated with 10, 25, or 50 mMC8-PtdIns5P, and production of IP-10 and RANTES
was analyzed by ELISA. GM-DCs were stimulated with C8-PtdIns5P for IFNb measurement.
(C) Mice were immunized intramuscularly with ovalbumin (OVA) and PBS, or C8-PtdIns5P or C8-PtdIns4,5P2, or immunized intraperitoneally with OVA and alum
as a positive control, and OVA-specific total IgG in sera was measured. IgG titers of each mouse was measured after 5 weeks (left). Time course analysis of IgG
titers (right).
(D) Wild-type, IRF3//IRF7/, or IPS-1 (MAVS)/mice were immunized intraperitoneally with OVA and alum, or intramuscularly immunized with OVA and C8-
PtdIns5P. OVA-specific total IgG in sera was measured.
(E) OVA-specificOT-II-transgenic CD4+ T cells were isolated and cocultured withGM-DCs treatedwith C8-PtdIns5P, C8-PtdIns4,5P2, or poly(I:C) in the presence
of OVA protein, and IFNg production was measured. Data are represented as mean ± SD. Figure 7 is related to Figure S6.
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(Bouwmeester et al., 2004; Fujita et al., 2003; Pomerantz and
Baltimore, 1999; Ryzhakov and Randow, 2007; Tanaka and
Chen, 2012).
PtdIns5P production is potentially mediated by several of the
kinases and phosphatases listed in Figure 2A, but our results
strongly suggest that innate immune signaling leads to PtdIns5P
production by PIKfyve (Figure 5). Other kinases and phospha-
tases that mediate PtdIns5P productionmay play roles in distinct
cellular signaling pathways (Figure S2A). For instance, although
H2O2 stimulation increased PtdIns5P production (Figure 5A), it
failed to produce type I IFN (data not shown). It was shown
that H2O2 stimulation produces PtdIns5P in the nucleus by
PI4K inhibition (Jones et al., 2006). PIKfyve localized in the
cytosol and partially colocalized with STING-positive organelles
and late endosomes. Production of PtdIns5P in organelles in the
cytosol is likely to be important for TBK1-IRF3 signal transduc-
tion (Figure 5). The activation mechanism of PIKfyve have not
been clearly understood so far, but PIKfyve might be activated
by association with STING or other adaptor molecules in organ-
elles for innate signaling.
PIKfyve can produce PtdIns3,5P2 fromPtdIns3P, a critical lipid
for organelle trafficking (Ikonomov et al., 2011; Rutherford et al.,
2006). It was suggested that in plasmacytoid DCs (pDCs), a
subset of DCs that produce type I IFN upon viral infection via
TLR7 or TLR9, PtdIns3,5P2 is enriched in the endosome
compartment where TLR9 is localized (Sasai et al., 2010). There-Cell Hosfore, we speculate that PIKfyve-dependent production of
PtdIns3,5P2 in pDCs plays important roles in virus infection-
induced type I IFN by regulating TLR9 trafficking in pDCs.
We also found that synthetic-C8-PtdIns5P promotes produc-
tion of cytokines such as IFNb, IP-10, and RANTES, which are
regulated by IRF3 (Figures 7A and 7B). Cytokine production by
synthetic-C8-PtdIns5P, among several phosphatidylinositols,
suggested that it was dependent on the phosphorylation site in
the inositol head, and not on the acyl chain. In addition, the pos-
sibility of LPS contamination in synthetic C8-PtdIns5P was ruled
out by the production of IP-10 in GM-DCs from Tlr2//Tlr4/
mice (data not shown). Although the precise mechanisms
underlying acyl length-specific cytokine production by PtdIns5P
are not clear (Figures 7A and 7B and Figure S6B), the cellular
incorporation rate of C8-PtdIns5P into GM-DCs may be appro-
priate for activation of TBK1-IRF3 signaling. Unlike poly(I:C),
C8-PtdIns5P strongly induced IP-10 and RANTES and weakly
induced IFNb in GM-DCs. This suggests that in addition to
IRF3 and IRF7, C8-PtdIns5P regulates unknown pathways
required for IP-10 and RANTES induction. These findings
suggested that PIKfyve-PtdIns5P-TBK1-IRF3 signaling axis is
activated in GM-DCs for the production of IFNb. Although C8-
PtdIns5P did not induce detectable amounts of IFNa/b in the
protein level in MEF cells, it increased IFNa/bmRNA expression,
which was diminished in TBK1/IKKi-deficient MEF cells (Fig-
ure S6F). Given that increased IFNb mRNA was also found in
MEFs, this axis is activated in MEF cells, but the signal activationt & Microbe 14, 148–158, August 14, 2013 ª2013 Elsevier Inc. 155
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should be clarified in the future.
C8-PtdIns5P also functions as an adjuvant in vivo that in-
creases antigen-specific antibody production and CD4+ T cell
responses (Figures 7C–7E). At present, a remarkable number
of ligands for PRRs have been discovered, some of them are
being clinically tested, and European and U.S. licensing author-
ities have recommended that novel adjuvants be evaluated in
nonclinical toxicology studies (Levitz and Golenbock, 2012).
C8-PtdIns5P activates the TBK1-IRF3 signaling axis, suggesting
that it could be useful as a new type of adjuvant.
EXPERIMENTAL PROCEDURES
Cells and Reagents
HEK293, HEK293T, and MEF cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% heat-inactivated fetal calf
serum (FCS, Life Technologies) in a 5% CO2 incubator. Preparation of MEF
cells and generation of IPS-1-deficient and TBK1/IKKi-deficient MEF cells
were described previously (Ishii et al., 2006; Kumar et al., 2006). GM-DCs
were obtained from mouse bone marrow cells cultured in RPMI 1640 medium
supplemented with 10% FCS, 100 mM 2-ME, and 10 ng/ml murine GM-CSF
(BD Biosciences) for 6–8 days. LPS, poly(I:C), R837, and poly(dA:dT) were
purchased from Invivogen, and DMXAA was purchased from Sigma. Sense
and anti-sense ISD sequenceswere synthesized (Grainer Japan) and annealed
(sense, 50-TACAGATCTACTAGTGATCTATGACTGATCTGTACATGATCTACA).
Poly(I:C) and poly(dA:dT) were mixed with Lipofectamine 2000 (Life Techno-
logies) at a ratio of 2:1 (mg:ml) in OptiMEM (Life Technologies) for stimulation.
C16-PtdIns, phosphatidylethanol, and PC were obtained from Avanti Polar
Lipid, and C8-PtdIns was obtained from Echelon Biosciences. YM-201636,
the PIKfyve inhibitor, was obtained from Santa Cruz. Antibodies were pur-
chased from the following companies: anti-PIKfyve (Sigma), anti-pIRF3 (Cell
Signaling), anti-pJNK (Cell Signaling), anti-TBK1 (Abcam), and anti-pTBK1
(Cell Signaling). ELISAs (R&D Systems) were performed according to the
manufacturer’s instructions.
Plasmid and Reporter Assay
The GFP-PIKfyve expression vector was a kind gift from Dr Tavare´ (Hill et al.,
2010). For construction of Flag-tagged PIKfyve, PIKfyve was amplified by PCR
and ligated into pFLAG-CMV6 vector. A kinase-negative mutation at K1831M
was introduced by KOD (Toyobo). Flag-tagged PIP5Ka, PIP5Kb, and PIP5Kg
were amplified from HEK293 cDNA and cloned into a pFlag-CMV6 vector.
PI3KIII, PTEN, TMEM55a, TMEM55b, and PI4K2a were obtained from a
cDNA library cloned into a pCMV-SPORT6 vector (Open Biosystems). Flag-
tagged IPS-1 and STING were described previously (Tsuchida et al., 2010).
HEK293 cells were seeded onto 24-well plates and transfected with an expres-
sion plasmid and a luciferase reporter plasmid using Lipofectamine 2000 (Life
Science Tech). After 16 hr, cells were lysed with passive lysis buffer (Promega),
and luciferase activity was measured using the dual-luciferase reporter assay
kit (Promega). The reporter plasmid for IFNb and ISRE was described
previously (Tsuchida et al., 2010). NF-kB activation was determined by the
ELAM- or NF-kB-luc reporter assay. TK promoter-driven Renilla luciferase
plasmid was used as an internal control.
In Vitro Phosphorylation
GST-tagged IRF3 was purified from Escherichia coli, and tags were eliminated
using precision protease (BD Biosciences) according to the manufacturer’s
instructions. GST-TBK1 was purified from HEK293T cells and eluted in
10 mM glutathione. For the in vitro kinase assay, 20 ng of TBK1 and
100 nmol of IRF3 were incubated in reaction buffer (10 mM ATP, 100 mM
NaCl, 2 mM MgCl2, 5 mM HEPES [pH 7.2]) at 30
C for 30 min. Liposomes
were formed at a ratio PC:PE:PI of 30:8:2 in reaction buffer by sonication
and subjected to in vitro kinase assay at 40 mM. GST-tagged STING was
expressed in HEK293T cells and purified using glutathione Sepharose beads.
Purified STING was reconstituted in azolectin lipid membrane by forming
liposomes under dialysis. Lipid separation was then performed.156 Cell Host & Microbe 14, 148–158, August 14, 2013 ª2013 ElseviProtein Lipid Overlay Assay
Purified IRF3 or GST-TBK1 proteins (100 nM) were incubated with membrane
lipid strips (Echelon Biosciences) or Hybond-C membrane (Amersham
Biosciences) spotted PtdIns5P in TBST buffer (140 mM NaCl, 2.5 mM KCl,
25 mM Tris [pH 8.0], 0.05% Tween 20). Membranes were washed three times
with TBST and incubated with anti-IRF3 or anti-TBK1, then further incubated
with secondary antibody for development.
Immunoprecipitation
RAW264.7 cells were lysed in lysis buffer (150 mM NaCl, 10 mM EGTA, 2 mM
EDTA, 25 mM Tris [pH 8.0], 0.1% NP40) after stimulation, and TBK1 was
precipitated by anti-TBK1 with IgA agarose beads (GE Healthcare) for 3 hr at
4C. Beads were washed three times, and bound proteins were separated
by SDS-PAGE.
siRNA and Quantitative RT-PCR
The target sequence for mouse PIKfyve is simPIKfyve1, 50-UAAAUAAGGAC
UCUUUGAUGAAGGC-30 (sense) simPIKfyve2; and 50-UCAGAAGGUUUCA
CAGGUGUACCUA-30 (sense) (Life Science Technology). The target sequence
for human PIKfyve is sihPIKfyve1, 50-UGAUUUGCCUCGAUCUCCUUU-30
(sense); and sihPIKfyve2, 50-AAAUCUCCUGCUCGAAAUAUU-30 (sense)
(Greiner). siRNA was electroporated by NEON (Life Technologies). Two days
after electroporation, MEF and HEK293 cells were stimulated with various
reagents or virus. Total RNA was isolated using Trizol reagent (Life Techno-
logies) and reverse transcribed by ReverTraAce (Toyobo) according to
the manufacturer’s instructions. Real-time PCR was performed using the
following primers: mIFNb, sense 50-ATGGTGGTCCGAGCAGAGAT-30, reverse
50-CCACCACTCATTCTGAGGCA-30; mIP-10, sense 50-CCATCAGCACCAT
GAACCCAAGT-30, reverse 50-CACTCCAGTTAAGGAGCCCTTTTAGACC-30;
mRANTES, sense 50- CTCACCATATGGCTCGGACA-30, reverse 50-ACAAA
CACGACTGCAAGATTGG-30; mGAPDH, sense 50-TGACGTGCCGCCTGGA
GAAA-30, reverse 50-AGTGTAGCCCAAGATGCCCTTCAG-30; mIL-6, sense
50-GTAGCTATGGTACTCCAGAAGAC-30, reverse 50-ACGATGATGCACTTGC
AGAA-30; and mPIKfyve, sense 50- AAGTCTTACCCTCACATGAGCTAGTGA-
30, reverse 50- ATCAGCTAGCATTCTACCCAAGGT-30. hPIKfyve, sense 50-T
GGATGCCAGATAGCCAATGT-30, reverse 50-TGTCTGCGCCTAAAGGTTG
TAAA-30.
PtdIns5P Mass Assay
A PtdIns5P conversion assay was performed as described by Morris et al.
(Morris et al., 2000). Briefly, PtdIns including PtdIns5P were isolated, and
the amount of PtdIns5P was detected by 32P incorporation by forming
PtdIns4,5P2 in an in vitro kinase assay. Cells were seeded onto 6-well plates
at a density of 23 105 cells per well. After stimulation, cells were collected and
lipids were isolated using chloroform/methanol (1:1; v/v). Total PtdIns were
further isolated using neomycin-coated glass beads prepared according to
previously reported procedures (Schacht, 1978) using glycerol controlled
pore glass (Sigma). Lipid extracts were incubated with 20 ml of packed
neomycin beads for 20 min in AF buffer (chloroform/methanol/330 mM ammo-
nium formate [5:10:1; v/v]), and beads were washed twice with AF buffer.
Bound PtdIns were eluted by chloroform/methanol/2.4 M HCl (5:10:4; v/v).
Eluted samples were exchanged in chloroform buffer and dried by SpeedVac
at a low/medium heat setting for 30 min after addition of 5 nmols of phospha-
tidylserine and 1.5 nmols of phosphatidic acid as a carrier. Dried PtdIns were
suspended in 40 ml of kinase assay buffer (80 mM KCl, 50 mM Tris [pH 7.4],
10 mM MgCl2, 2 mM EGTA) by sonication, and a PtdIns conversion assay
was started by incubation with 0.1 mg of bacterially expressed PI4KIIa for
2 hr at 30C in the presence of [gamma 32P] ATP. PI4KIIa was subcloned in
a pGEX vector (GE Healthcare), and recombinant protein was purified from
E. coli. The reaction was terminated by addition of 200 ml of 1 M HCl, and pro-
tein was extracted with 160 ml of chloroform/methanol (1:1; v/v). The lower
layers were washed twice with 100 ml of methanol/1 M HCl (1:1; v/v), and
phosphorylated PtdIns5P (Ptd4,5P2) was separated by thin-layer chromatog-
raphy (TLC). Then 15 ml of the lower layers was spotted onto a TLC silica
plate (GE Healthcare) and separated by chloroform/methanol/5.6% ammo-
nium in water (45:35:10; v/v). The TLC plate was dried and developed on
an imaging plate, and 32P densitometries were counted using a Typhoon
FLA7000 system (Fuji Film).er Inc.
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Ins1,5P2 ligand was created from the Ins1,4,5P3 ligand, and 1J2F (Takahasi
et al., 2003) was used as a receptor. The hydrogen positions and Gasteiger
charges were calculated by Autodock tools. The Autodock4 (Morris et al.,
2009) and Autodock vina (Trott and Olson, 2010) programs were run using
default parameters.
Mouse Immunization
IPS-1deficient (Mavs)/, Irf3//Irf7/, and OT-II mice have been described
previously (Kumar et al., 2006; Uematsu et al., 2008). All animal experiments
were performed with the approval of the Animal Research Committee of the
Research Institute for Microbial Diseases at Osaka University. For mice
immunizations, C57BL/6J mice (Japan Clea) were immunized intraperitoneally
with 100 mg of OVA (Seikagaku Corporation) and 1 mg of alum (Sigma) or
immunized intramuscularly with 100 mg of OVA/100 mg of C8-PtdIns every
week for a total of four immunizations. C8-PtdIns5P and C8-PtdIns4,5P2
were solubilized in PBS and mixed with OVA for immunization. For coculture
experiments, 1 3 105 OVA-specific OT-II-transgenic CD4+ T cells and 1 3
105 GM-DCs treated with C8-PtdIns5P, C8-PtdIns4,5P2 or poly(I:C) were
cultured in the presence of 10 mg of OVA protein for 7 days, and IFNg produc-
tion was measured.
Statistics
Statistical significance was determined by Student’s t test. A p value of <0.05
was considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and can be found with this
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